您的位置: 首页 > 农业专利 > 详情页

COMPOSITIONS ET PROCEDES DE MODULATION DE L'EXPRESSION DE LA FAMILLE GENIQUE SMN
专利权人:
THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL;RANA THERAPEUTICS INC.
发明人:
KRIEG, ARTHUR M.,SUBRAMANIAN, ROMESH,MCSWIGGEN, JAMES,LEE, JEANNIE T.
申请号:
CA2873794
公开号:
CA2873794A1
申请日:
2013.05.16
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
Aspects of the invention provide single stranded oligonucleotides for activating or enhancing expression of SMNl or SMN2. Further aspects provide compositions and kits comprising single stranded oligonucleotides for activating or enhancing expression of SMNl or SMN2 that comprises exon 7. Methods for modulating expression of SMNl or SMN2 using the single stranded oligonucleotides are also provided. Further aspects of the invention provide methods for selecting a candidate oligonucleotide for activating or enhancing expression of SMNl or SMN2.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充